Clinical Trials on Vulvo-vaginal Candidiasis in Hong Kong
Total 16 results
-
Chinese University of Hong KongRecruitingVaginal Abnormality | Abnormalities UterineHong Kong
-
The University of Hong KongUnknownDental Restoration Failure of Marginal IntegrityChina
-
PfizerTerminatedCandidiasisHong Kong, Hungary, China, Czech Republic, Mexico, Philippines, Poland, Slovakia
-
PfizerVicuron PharmaceuticalsCompleted
-
PfizerVicuron PharmaceuticalsCompleted
-
PfizerCompletedCandidemiaUnited States, Taiwan, Spain, United Kingdom, Korea, Republic of, Brazil, Greece, Canada, Italy, Russian Federation
-
PfizerVicuron PharmaceuticalsCompleted
-
Lupin Research IncCompletedBacterial VaginosesUnited States
-
Insud PharmaAllergan Sales, LLCCompleted
-
Ferring PharmaceuticalsCompletedInduction of Labor | Cervical Ripening | Reducing Time to Vaginal DeliveryUnited States
-
Bristol-Myers SquibbCompletedSepsis | Candidemia | Staphylococcal Infections | Nosocomial InfectionsUnited States, Canada
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Small Lymphocytic LymphomaUnited States, United Kingdom, Italy, Germany, Poland, France
-
MEI Pharma, Inc.Kyowa Kirin, Inc.TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma | Malignant Mesothelioma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Gestational Trophoblastic Tumor | Cervical Adenocarcinoma and other conditionsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
National Cancer Institute (NCI)RecruitingLymphoplasmacytic Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Grade 3b Follicular... and other conditionsUnited States